The time course and effect on serum electrolytes of oral sodium phosphates solution in healthy male and female volunteers.

BACKGROUND Although oral sodium phosphates solution is used extensively for bowel preparation, the pharmacokinetic profile of 2 x 45 mL oral sodium phosphates solution has not been reported. OBJECTIVES The primary objective of this study was to evaluate the time course and degree of electrolyte shifts in two age groups and two gender groups following administration of oral sodium phosphates solution. Secondary objectives included evaluation of electrocardiograms, postural blood pressure, standard serum chemistry and hematology panels, and adverse experiences. METHODS Twenty-four healthy adult volunteers were divided equally into groups based on age and gender. Each received 2 x 45 mL oral sodium phosphates solution at 7:00pm (hour 0) and at 7:00am (hour 12). Serum electrolytes were measured at sixteen different time points. RESULTS Mean serum phosphate concentrations exceeded the upper normal limit within 1 hour following the first dose, peaking at 3 hours (6.26 mg/dL; p < 0.0001) before decreasing. Following the second dose at 12 hours, mean serum phosphate concentrations peaked at 14 hours (6.86 mg/dL; p < 0.0001), before decreasing to normal limits by hour 24. Mean serum sodium, potassium, and calcium concentrations fluctuated within the normal range. However, serum sodium concentrations peaked at 1 hour following the second dose of phosphate, showing a statistically significant (p < 0.0001) increase of 2.4% from baseline to 144.8 mmol/L. No clinically significant changes in ECG were observed. Mean reductions in supine and standing systolic blood pressure were not associated with postural change. No subject had postural decreases in systolic blood pressure of greater than 20 mmHg. CONCLUSIONS Administration of 2 x 45 mL oral sodium phosphates solution 12 hours apart with proper hydration caused transient serum electrolyte shifts, which were clinically insignificant and resolved within 24 hours.

[1]  H. Murer,et al.  Proximal tubular handling of phosphate: A molecular perspective. , 2006, Kidney international.

[2]  S. Dutta,et al.  Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. , 2006, Endoscopy.

[3]  Jai Radhakrishnan,et al.  Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  C. Berkelhammer,et al.  Colonoscopy Bowel Preparation in Patients with Long QT Syndrome: 597 , 2005 .

[5]  H. Tenenhouse.  Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter. , 2005, Annual review of nutrition.

[6]  C. Wagner,et al.  Regulation of intestinal phosphate transport. II. Metabolic acidosis stimulates Na(+)-dependent phosphate absorption and expression of the Na(+)-P(i) cotransporter NaPi-IIb in small intestine. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[7]  J. Dipalma,et al.  Bowel preparation for gastrointestinal procedures , 2004, Current gastroenterology reports.

[8]  S. Vanner,et al.  Recognizing the clinical contraindications to the use of oral sodium phosphate for colon cleansing: a case study. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[9]  J. Tjandra,et al.  Carbohydrate-Electrolyte (E-Lyte®) Solution Enhances Bowel Preparation With Oral Fleet® Phospho-soda® , 2004, Diseases of the colon and rectum.

[10]  V. D’Agati,et al.  Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. , 2004, Human pathology.

[11]  Y. Gumurdulu,et al.  Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation , 2004, Journal of gastroenterology and hepatology.

[12]  H. Murer,et al.  Regulation of Na/Pi transporter in the proximal tubule. , 2003, Annual review of physiology.

[13]  B. Gamulka.  Case 2: First do no harm. , 2003, Paediatrics & child health.

[14]  T. Truong.  Case 1: The girl who couldn't sit still. , 2003, Paediatrics & child health.

[15]  M. Bergeron,et al.  Acute phosphate nephropathy and renal failure. , 2003, The New England journal of medicine.

[16]  J. Love.  The appropriate use of sodium phosphates oral solutions. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[17]  C. Ng,et al.  Severe hyperphosphatemia and hypocalcemia following sodium phosphate bowel preparation: a forgotten menace. , 2003, Endoscopy.

[18]  William O Thompson,et al.  Low Volume Bowel Preparation for Colonoscopy: Randomized, Endoscopist-Blinded Trial of Liquid Sodium Phosphate Versus Tablet Sodium Phosphate , 2003, American Journal of Gastroenterology.

[19]  S. Vanner,et al.  Carbohydrate-electrolyte rehydration protects against intravascular volume contraction during colonic cleansing with orally administered sodium phosphate. , 2002, Gastrointestinal endoscopy.

[20]  C. Berkelhammer,et al.  Low-volume oral colonoscopy bowel preparation: sodium phosphate and magnesium citrate. , 2002, Gastrointestinal endoscopy.

[21]  K. C. Chan,et al.  Two Liters of Polyethylene Glycol-Electrolyte Lavage Solution Versus Sodium Phosphate as Bowel Cleansing Regimen for Colonoscopy: A Prospective Randomized Controlled Trial , 2002, Endoscopy.

[22]  R. Hawkins,et al.  Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation , 2002, Anaesthesia.

[23]  P. Jm,et al.  Characterization of the safety, effectiveness and use of oral sodium phosphate. , 2001 .

[24]  R. R. Simpson,et al.  Oral sodium phosphate solution is a superior colonoscopy preparation to polyethylene glycol with bisacodyl , 2000, Diseases of the colon and rectum.

[25]  W. Lipshutz,et al.  A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. , 2000, Gastrointestinal endoscopy.

[26]  F. Port,et al.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  S. Kahn,et al.  Symptomatic hypocalcemia from oral sodium phosphate: a report of two cases , 1998, American Journal of Gastroenterology.

[28]  D. Frommer,et al.  Cleansing ability and tolerance of three bowel preparations for colonoscopy , 1997, Diseases of the colon and rectum.

[29]  D. Lieberman,et al.  Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine. , 1996, Gastrointestinal endoscopy.

[30]  R. M. Culpepper,et al.  Biochemical effects of oral sodium phosphate , 1995, Digestive Diseases and Sciences.

[31]  J. Nogueras,et al.  Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods , 1994, Diseases of the colon and rectum.

[32]  W G Paterson,et al.  A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy. , 1990, The American journal of gastroenterology.

[33]  L. Opas,et al.  Phosphate poisoning complicating treatment for iron ingestion. , 1980, American journal of diseases of children.

[34]  A. Carrera.  Effect of oral administration of Fleet phospho-soda on serum phosphorus concentration. , 1968, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists.

[35]  Hulya Akgun,et al.  Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. , 2006, Archives of pathology & laboratory medicine.

[36]  L. Bujanda,et al.  [Tolerance to and colon cleansing with 2 preparations. Polyethylene glycol or sodium phosphate]. , 2001, Gastroenterologia y hepatologia.

[37]  S. Rodríguez Muñoz,et al.  Characterization of the safety, effectiveness and use of oral sodium phosphate. , 2001, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[38]  W. Paterson,et al.  Safety profile of 5-h oral sodium phosphate regimen for colonoscopy cleansing: lack of clinically significant hypocalcemia or hypovolemia. , 1995, The American journal of gastroenterology.